ArticleAmerican journal of cancer research2013

Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer.

Takao Ohnuma et al.PubMed ↗Full text ↗

No numbers read from the abstract.